Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: Its clinical significance

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 2, 2001, Pages 157-161

  Nagai, Toshiyuki ^a   Murota, Masayuki ^a   Nishioka, Mikio ^a   Fujita, Jiro ^a   Ohtsuki, Yuji ^b   Dohmoto, Kazutaka ^a   Hojo, Satoko ^a   Dobashi, Naomi ^a   Takahara, Jiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cytokeratin 19 fragment; Hepatoma; Immunohistochemistry; Liver cirrhosis

Indexed keywords

ALPHA FETOPROTEIN; ANTIBODY; CYTOKERATIN 19; DECARBOXYPROTHROMBIN; PROTHROMBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; AGED; ALPHA-FETOPROTEINS; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035136874     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200102000-00011     Document Type: Article

References (28)

1. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
2. Fuchs E. Keratins as biochemical markers of epithelial differentiation. Trends Genet 1988; 4: 277-281.
3. Coulombe PA. The cellular biology of keratins: beginning a new era. Curr Opin Cell Biol 1993; 5: 17-29.
4. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments. J Invest Dermatol 1993; 100: 729-734.
5. Pujol JL, Grenier J, Daures JP, Daver A, Pujol H, Michel FB. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53: 61-66.
6. Pujol JL, Grenier J, Parrat E, Lehmann M, Lafontaine T, Quanyin X. et al. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med 1996; 154: 725-733.
7. Bartek J, Bartkova J, Taylor-Papadimitriou J, Rejthar A, Kovarik J, Lukas Z. et al. Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies. Histochem J 1986; 18: 565-575.
8. Kasper M, Stosiek P, Typlt H, Karsten U. Histological evaluation of three new monoclonal anti-cytokeratin antibodie.: 1. Normal tissues. Eur J Cancer Clin Oncol 1987; 23: 137-147.
9. Osborn M, Van Lessen G, Weber K, Kloppel G, Altmannsberger M. Methods in laboratory investigation.: Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986; 55: 497-504.
10. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987; 170: 235-249.
11. Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver diseases: evidence that hepatocytes can express ‘bile duct-type’ cytokeratins. Histopathology 1989; 15: 125-135.
12. Van Eyken P, Sciot R, Paterson A, Callea F, Kew MC, Desmet VJ. Cytokeratin expression in hepatocellular carcinoma.: An immunohistochemical study. Hum Pathol 1988; 19: 562-568.
13. Savtchenko ES, Schiff TA, Jiang CK, Freedberg IM, Blumenberg M. Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogene sequence. Am J Hum Genet 1988; 43: 630-637.
14. Ruud P, Fodstad O, Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999; 80: 119-125.
15. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475-482.
16. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R. et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 2632-2640.
17. Tsuji M, Kashihara T, Terada N, Mori H. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19. Pathol Int 1999; 49: 310-317.
18. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998; 33: 318-324.
19. Kashihara T, Ohki A, Kobayashi T, Sato T, Nishizawa H, Ogawa K. et al. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level. J Gastroenterol 1998; 33: 447-453.
20. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993; 13: 113-122.
21. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme ‘ductal plate malformation’. Hepatology 1992; 16: 1069-1082.
22. Gerber MA, Thung SN, Shen S, Stromeyer FW, Ishak KG. Phenotypic characterization of hepatic proliferation.: Antigen expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol 1983; 110: 70-74.
23. Uchida T, Peters RL. The nature and origin of proliferated bile ductules in alcoholic liver diseases. Am J Clin Pathol 1983; 79: 326-333.
24. Desmet V, Roskams T, van Eyken P. Ductular reaction in the liver. Pathol Res Pract 1995; 191: 513-524.
25. James J, Lygidakis NJ, van Eyken P, Tanka AK, Bosch KS, Racemaekers FC. et al. Application of keratin immunocytochemistry and sirius red staining, in evaluation of intrahepatic changes with acute extrahepatic cholestasis due to hepatic duct carcinoma. Hepatogastroenterology 1989; 36: 151-155.
26. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466-477.
27. Green JA, Carthew P, Heuillet E, Simpson JL, Manson MM. Cytokeratin expression during AFB1-induced carcinogenesis. Carcinogenesis 1990; 11: 1175-1182.
28. Zvibel I, Brill S, Reid LM. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas. J Cell Physiol 1995; 162: 36-43.